Pharma news
Pharma
The supplementary protection certificate manufacturing waiver “sends a worrying global signal that the EU is weakening its IP framework”, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA). 18 October 2018
Americas
The US Food and Drug Administration has allowed the first US-based human trial of CRISPR, the gene-editing technology, to proceed. 17 October 2018
Americas
After spending four years at Hughes Hubbard & Reed, Stephen Rabinowitz has joined Dechert’s New York office as a partner. 17 October 2018
Pharma
The European Commission’s proposed export waiver for supplementary protection certificates has exposed a number of likely flaws which have not gone down well with patent owners. LSIPR reports. 17 October 2018
Pharma
The case of Actavis v Eli Lilly introduced “a real change in the law” and the way in which it addresses the doctrine of equivalence, according to Douglas Drysdale, partner at HGF in Glasgow, UK. 16 October 2018
Americas
The US Court of Appeals for the Federal Circuit has upheld two decisions that said patents relating to the dosage of Teva’s Copaxone 40mg/mL treatment are invalid. 15 October 2018
Americas
Samsung and HP are just two technology companies that have diversified and invested in the life sciences industry. What impact will this type of activity have on the sector and will it be beneficial in the long run? LSIPR finds out. 15 October 2018
Americas
AbbVie has announced yet another settlement relating to litigation over Humira, a drug used to treat multiple types of arthritis as well as psoriasis. 12 October 2018
Americas
Eli Lilly has filed a complaint against France-based biotechnology company Adocia over patents relating to fast-acting insulin. 11 October 2018
Americas
The US Food and Drug Administration has released guidance intended to advance the development of generic versions of complex medical drugs. 11 October 2018